Interestingly, our previous work showed that the EPHB6 receptor suppresses aggressiveness of breast cancer cells by interacting with EPHB4 and interfering with EPHB4 action [29], which implies that EPHB6 may also enhance the DR4- or DR5- mediated apoptotic response. Here, EPHB6 is linked to breast cancer.